UB Paderborn / Katalog / Suche / in CDI

Transarterial chemoembolization plus a PD‐1 inhibitor with or without lenvatinib for intermediate‐stage hepatocellular carcinoma

Hepatology research, 2022-08, Vol.52 (8), p.721-729

2022

Volltextzugriff (PDF)

Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation

BMC cancer, 2023-10, Vol.23 (1), p.1-1017, Article 1017

2023

Volltextzugriff (PDF)

Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors

BMC cancer, 2023-06, Vol.23 (1), p.547-547, Article 547

2023

Volltextzugriff (PDF)

Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study

Cancer medicine (Malden, MA), 2023-05, Vol.12 (10), p.11513-11524

2023

Volltextzugriff (PDF)

A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study

Cancer medicine (Malden, MA), 2023-05, Vol.12 (9), p.10294-10302

2023

Volltextzugriff (PDF)

Response to: “Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues”

Hepatology international, 2023-10, Vol.17 (5), p.1322-1323

2023

Volltextzugriff (PDF)

Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence

Technology in Cancer Research & Treatment, 2023-01, Vol.22, p.15330338231212726-15330338231212726

2023

Volltextzugriff (PDF)

Actual long-term survival in hepatocellular carcinoma patients with microvascular invasion: a multicenter study from China

Hepatology international, 2021-06, Vol.15 (3), p.642-650

2021

Volltextzugriff (PDF)

Camrelizumab plus gemcitabine and oxaliplatin for the treatment of advanced intrahepatic cholangiocarcinoma: a bi-centric observational retrospective study

Frontiers in oncology, 2023-05, Vol.13, p.1101038-1101038

2023

Volltextzugriff (PDF)

Serum metabolomics analysis of biomarkers and metabolic pathways in patients with colorectal cancer associated with spleen-deficiency and qi-stagnation syndrome or damp-heat syndrome: a prospective cohort study

Frontiers in oncology, 2023-09, Vol.13, p.1190706-1190706

2023

Volltextzugriff (PDF)

Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory

Frontiers in oncology, 2022-03, Vol.12, p.839605-839605

2022

Volltextzugriff (PDF)

Image-matching digital macro-slide—a novel pathological examination method for microvascular invasion detection in hepatocellular carcinoma

Hepatology international, 2022-04, Vol.16 (2), p.381-395

2022

Volltextzugriff (PDF)

Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study

Hepatology international, 2023-10, Vol.17 (5), p.1251-1264

2023

Volltextzugriff (PDF)

Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world

Frontiers in oncology, 2022-11, Vol.12, p.954203-954203

2022

Volltextzugriff (PDF)

Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0–A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis

Hepatology international, 2022-08, Vol.16 (4), p.892-905

2022

Volltextzugriff (PDF)

A stable and reliable animal model for hepatocellular carcinoma with portal vein tumor thrombus

Hepatobiliary & pancreatic diseases international, 2022-02, Vol.21 (1), p.90-93

2022

Volltextzugriff (PDF)

Impact of type 2 diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: A multicenter retrospective study

Frontiers in oncology, 2022-12, Vol.12, p.979434-979434

2022

Volltextzugriff (PDF)

Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score Matching Analysis

Frontiers in oncology, 2022-03, Vol.12, p.835559-835559

2022

Volltextzugriff (PDF)

Postoperative adjuvant aspirin for patients with hepatitis B virus-related hepatocellular carcinoma and portal vein tumor thrombus: An open-label, randomized controlled trial

Heliyon, 2023-09, Vol.9 (9), p.e20015-e20015, Article e20015

2023

Volltextzugriff (PDF)

Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism

Frontiers in nutrition (Lausanne), 2023-02, Vol.10, p.1076569-1076569

2023

Volltextzugriff (PDF)

Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Letter]

Cancer management and research, 2021-01, Vol.13, p.987-988

2021

Volltextzugriff (PDF)

Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study

Frontiers in oncology, 2021-07, Vol.11, p.697073-697073

2021

Volltextzugriff (PDF)

Efficacy and Safety of Transarterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma Associated with Bile Duct Tumor Thrombus: A Real-World Retrospective Cohort Study

Cancer management and research, 2021-01, Vol.13, p.3551-3560

2021

Volltextzugriff (PDF)

Prognostic and Immunotherapeutic Predictive Value of CAD Gene in Hepatocellular Carcinoma: Integrated Bioinformatics and Experimental Analysis

Molecular biotechnology, 2024-04

2024

Volltextzugriff (PDF)

A new and rare type of hepatocellular carcinoma: Survival and gene analysis of portal vein tumour thrombus-type hepatocellular carcinoma

Pathology, research and practice, 2023-01, Vol.241, p.154260-154260, Article 154260

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Transarterial chemoembolization plus a PD‐1 inhibitor with or without lenvatinib for intermediate‐stage hepatocellular carcinoma

Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation

Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors

Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study

A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study

Response to: “Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues”

Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence

Actual long-term survival in hepatocellular carcinoma patients with microvascular invasion: a multicenter study from China

Camrelizumab plus gemcitabine and oxaliplatin for the treatment of advanced intrahepatic cholangiocarcinoma: a bi-centric observational retrospective study

Serum metabolomics analysis of biomarkers and metabolic pathways in patients with colorectal cancer associated with spleen-deficiency and qi-stagnation syndrome or damp-heat syndrome: a prospective cohort study

Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory

Image-matching digital macro-slide—a novel pathological examination method for microvascular invasion detection in hepatocellular carcinoma

Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study

Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world

Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0–A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis

A stable and reliable animal model for hepatocellular carcinoma with portal vein tumor thrombus

Impact of type 2 diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: A multicenter retrospective study

Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score Matching Analysis

Postoperative adjuvant aspirin for patients with hepatitis B virus-related hepatocellular carcinoma and portal vein tumor thrombus: An open-label, randomized controlled trial

Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism

Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Letter]

Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study

Efficacy and Safety of Transarterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma Associated with Bile Duct Tumor Thrombus: A Real-World Retrospective Cohort Study

Prognostic and Immunotherapeutic Predictive Value of CAD Gene in Hepatocellular Carcinoma: Integrated Bioinformatics and Experimental Analysis

A new and rare type of hepatocellular carcinoma: Survival and gene analysis of portal vein tumour thrombus-type hepatocellular carcinoma

Suchergebnisse filtern